About Event
This conference focuses on translational aspects of substance use research among chemists, biologists, and behavioral scientists. The diversity of participants and attendees at this meeting (undergraduate students to senior faculty, chemists to psychiatrists) provides a unique venue for networking among different disciplines and in so doing promotes new and innovative approaches to medications development in addictions biology. The meeting provides a stimulating environment for young scientists who are strongly encouraged to present their work and interact with senior scientists. The BBC meeting has served as a “launch pad” for many young, innovative investigators to join the ever-growing world of SUD research.
| --> | Registration Fees
$175 | Presenting Students and Postdocs (waived for travel awardees)
|
Event Speakers
 |
Rita Valentino, PhDNational Institute on Drug Abuse |
The neuroscience of addiction |
|
.jpg) |
Nurulain (Nur) Zaveri, PhDAstraea Therapeutics, LLC |
Targeting the alpha3beta4 neuronal nicotinic acetylcholine receptors for nicotine and other substance use disorders: Rationale, preclinical validation and progress towards clinical translation. |
Plenary Symposium
 |
Daniel Rosenbaum, PhDUT Southwestern Medical Center |
Orexin receptor structural biology and its use in drug discovery |
|
 |
Stephanie Borgland, PhDUniversity of Calgary | 200
Co-release of orexin and dynorphin in the modulation of VTA dopamine neurons and opioid seeking
|
|
 |
Yanan Zhang, PhDResearch Triangle Institute |
Sleep and Addiction: Development of orexin receptor modulators |
|
 |
Andrew Huhn, PhD, MBAJohns Hopkins Medicine |
Orexin antagonist effects on sleep and stress during opioid withdrawal |